Azvudine beats paxlovid in reducing COVID-19 deaths
A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer.
Study: Real‐world effectiveness and safety of oral azvudine versus…
Read More...
Read More...